Cat. No. 3757
Alternative Names: Tikosyn, UK 68798
Chemical Name: 1-(4-Methanesulphonamidophenoxy)-2-
Biological ActivitySelective potassium channel blocker. Blocks KV11.1 (hERG) channels; inhibits the rapid delayed-rectifier K+ current (IKr). Displays class III antiarrhythmic properties.
Licensing InformationSold for research purposes under agreement from Pfizer Inc.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
Finlayson et al (2001) [3H]Dofetilide binding in SHSY5Y and HEK293 cells expressing a HERG-like K+ channel. Eur.J.Pharmacol. 412 203. PMID: 11166283.
Carmeliet (1992) Voltage- and time-dependent block of delayed K+ current in cardiac myocytes by dofetilide. J.Pharmacol.Exp.Ther. 262 809. PMID: 1501123.
Gwilt et al (1991) UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells. J.Pharmacol.Exp.Ther. 256 318. PMID: 1988662.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for Dofetilide include:
Bhave et al (2011) Development of a selective small-molecule inhibitor of Kir1.1, the renal outer medullary potassium channel. Mol Pharmacol 79 42. PMID: 20926757.
Do you know of a great paper that uses Dofetilide from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Dofetilide, supplier, UK68798, hERG, K+, potassium, channels, blockers, inhibits, IKR, delayed, rectifier, currents, Kv, voltage-gated, voltage-dependent, Human, Ether-A-Go-Go, Gene, Pfizer, KV11.1, Tocris Bioscience, Voltage-gated Potassium (KV) Channel Blocker products
Find multiple products by catalog number
New Products in this Area
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.